Allurion Technologies Inc. is cleared by regulators in France to resume sales of its swallowable gastric balloon to treat ...

The scientific establishment has launched a fight back against the Trump administration and the slew of executive orders that ...

New research has uncovered a complex interplay between extracellular matrix (ECM) structure and the transcriptional responses ...

Coming as no surprise, the U.S. Senate’s Feb. 13 confirmation of Robert Kennedy as the next secretary of the Department of ...

European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech ...

Med-tech companies secured $2.76 billion across financings 56 transactions in January 2025, up from $1.72 billion in December ...

Genescience Pharmaceuticals Co. Ltd. has prepared and tested new fibroblast growth factor receptor 2 (FGFR2) and/or FGFR3 inhibitors reported to be useful for the treatment of cancer, ...

A recent patent application from Laleh Rad, associate professor of Biomedical Engineering and Radiology at Northwestern University, describes the use of machine learning for real-time risk assessment ...

The BioWorld Cancer Index (BCI) experienced a steep decline in 2024, closing the year down 17.32%. After peaking in late February with an 11.16% gain, the index steadily trended downward, with only ...

TB Alliance has disclosed new ATP-dependent Clp protease ClpP1P2 complex (Mycobacterium tuberculosis) inhibitors reported to be useful for the treatment of tuberculosis.

High-grade serous ovarian cancer (HGSC) is among the most lethal gynecologic malignancies, with up to 90% of patients eventually becoming resistant to platinum-based chemotherapy. The limited ...

Bind Research has launched as a not-for-profit focused research organization (FRO) with the aim of transforming disordered proteins into viable drug targets. The organization has secured financing ...